Sara M. Tolaney, MD, MPH, and shared her views and perspective on antibody-drug conjugates and their impact on patint outcomes. Listen to her brief interview with CancerNetwork® . cancernetwork.com/view/antibody-…

Today we announced our involvement with CancerX , a partnership with the The White House, to unleash the power of innovation and reduce the burden of cancer for everyone. ➡️bwnews.pr/3seL3Rp

Connect with our SimBioSys team at the 13th Annual #WorldCBCDx Summit! Learn more about our #spatialbiology approach for #biomarkerdevelopment in #oncology.

We’re excited to showcase our #surgicalplanning platform at the AGBT Meeting #PrecisionHealth, an annual meeting that keeps bringing innovative technologies to light. Our Director of Bioinformatics & Metabolism, Dr. Daniel Cook, will present our technology tomorrow @ 4:35 p.m.-6:35 p.m.

If you are attending the #AGBT #PrecisionHealth meeting today, don’t miss out on the opportunity to connect with Dr. Daniel Cook during his poster presentation from 4:35 p.m. to 6:35 p.m. Learn more about our next-generation technology for #surgicalplanning.

We are thrilled to be part of the Chicago biotech community supporting the CancerX initiative and partnering with @_DiMeSociety and Moffitt Cancer Center in the fight against #cancer. Read more about our involvement with the initiative as a founding member. chicagobusiness.com/health-care/ch…

This week CancerX announced its strategic priorities for 2023-2024 and its inaugural steering committee aligning their priorities with the broader Cancer Moonshot community. Learn about CancerX strategic priorities here: cancerx.health/about-cancerx/…

Check out this recent Journal of Clinical Pathways article by Matthew Biancalana and Tushar Pandey. They discuss how #AI can enhance the field of precision medicine and help unburden physicians from laborious and repetitive tasks in diagnostic analyses: hmpgloballearningnetwork.com/site/jcp/artif…

SimBioSys CEO Tushar Pandey was interviewed in a recent episode of the CRPN Central Podcast. It's always great to hear from EnterpriseWorks tenants: listen to this podcast today at drfoxt.podbean.com/e/breast-cance….

October is #BreastCancerAwarenessMonth. We've made much progress in treating this disease, but we can still do better. We’re developing our TumorSight technology to help doctors create treatment plans that are personalized for each patient – learn more: simbiosys.com

Join us at the Spatial Biology for Drug Development Summit to explore how this rapidly changing technology is becoming a crucial component of successful drug development programs and how we can help. Learn more: spatialbiology-drugdevelopment.com

If you’re attending the conference, please be sure to attend our presentation with Joseph Peterson on Friday and stop by Booth #1 to learn more about how PhenoScope™ Discovery can help uniquely advance your cancer research capabilities.

🎗️Today, on #MetastaticBreastCancerAwarenessDay, we raise awareness for the thousands of individuals battling this chronic disease. SimBioSys is dedicated to helping to individualize care and improve outcomes. Learn more to #LightUpMBC: metavivor.org/take-action/ca…

As #BreastCancerAwarenessMonth ends, we reflect on how we can better serve patients so that they may live longer & better. Dr. Barry Rosen shares how recent tech, including our TumorSight platform, can help ensure that patients receive the best care. tinyurl.com/nhcajebd

As our product pipeline continues to advance, now is the perfect time to update our website to reflect all of our important progress! Learn more about the exciting things happening, including the latest on our TumorSight and PhenoScope platforms: simbiosys.com

Interested in learning more about the latest advancements and tools in cancer drug discovery? Our CTO and Co-founder Dr. Joseph Peterson will be speaking alongside other leaders in the field during Drug Discovery World's Cancer Summit! Register: register.gotowebinar.com/register/24536…

It’s not too late to register for Drug Discovery World's Cancer Summit! Join our CTO and Co-founder, Dr. Joseph Peterson, alongside other leaders in the field to discuss the latest advancements in cancer drug discovery research. Register here: register.gotowebinar.com/register/24536…

We are excited to announce a strategic collaboration with the Mayo Clinic for the development of novel digital medicine solutions for patients to help improve quality of life, starting with #breastcancer. Read more about this exciting collaboration here: businesswire.com/news/home/2024…

We are thrilled to announce our first FDA 510(k) clearance for our digital precision medicine technology, TumorSight™! This milestone allows us to deliver on our vision to redefine precision medicine and revolutionize patient care. Read more here: businesswire.com/news/home/2024…

🎙 Listen to Dr Jeremy Skillington, CEO of Poolbeg Pharma and Tushar Pandey, CEO and Co-founder of SimBioSys, as they discuss the growing role of #AI in drug development on the latest episode of #OptimumPerspectives! Stream the full episode here: Optimum Perspectives Podcast –